Symptom control in advanced gastrointestinal cancer

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 4, 2000, Pages 375-379

  Baines, Mary J ^a  

^a Ellenor Foundation   (United Kingdom)

Author keywords

Advanced gastrointestinal cancer; Cancer pain; Intestinal obstruction; Palliative medicine; Symptom control

Indexed keywords

ANALGESIC AGENT; BISACODYL; BUPRENORPHINE; CODEINE; CORTICOSTEROID; CYCLIZINE; DEXAMETHASONE; FENTANYL; GRANISETRON; HALOPERIDOL; HYDROMORPHONE; LACTULOSE; LEVOMEPROMAZINE; METHADONE; METOCLOPRAMIDE; MORPHINE; OCTREOTIDE; ONDANSETRON; OPIATE; PARACETAMOL; PETHIDINE; PHENAZOCINE; POLOXAMER; SCOPOLAMINE BUTYL BROMIDE; TRAMADOL; TROPISETRON;

ANOREXIA; CONSTIPATION; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; DRUG METABOLISM; HUMAN; INTESTINE OBSTRUCTION; MYOCLONUS SEIZURE; NAUSEA; PAIN; PRIORITY JOURNAL; REVIEW; SENNA; VOMITING;

EID: 0033999191     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012040-00002     Document Type: Review

References (20)

1. 1 Cancer Pain Relief and Palliative Care. Geneva: World Health Organization, 1990.
2. 2 Vainio A, Auvinem A. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Mgmt 1996; 12:3-10.
3. 3 O'Neill B, Fallon M. Principles of palliative care and pain control. BMJ 1997; 315:801-804.
4. 4 Hanks GW. Morphine in cancer pain: modes of administration. Expert Working Group of the European Association for Palliative Care. BMJ 1996; 312:823-826. A clear guide on the use of morphine in cancer pain, written by experts from seven European countries. Doses, routes of administration and problems associated with morphine are covered.
5. 5 Vainio A. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 1995; 346:667-670. Patients on stable doses of morphine have minimal alteration of cognitive function and are allowed to drive.
6. 6 Sykes J, Johnson R, Hanks GW. Difficult pain problems. BMJ 1997; 315:867-869. This article describes the management of cancer pains which are opioid-resistant, such as neuropathic pain and pain from bone metastases.
7. 7 Needham PR, Hoskin PJ. Radiotherapy for painful bone metastases. Palliative Medicine 1994; 8:95-104.
8. 8 Tchekmedyian NS, Hickham M, Siau J, Greco FA, Keller J, Browder H, Aisner J. Megestrol acetate in cancer anorexia and weight loss. Cancer 1992; 69:1268-1274. Megestrol has been shown, in a randomized double-blind placebo-controlled trial, to significantly improve appetite and weight in patients with advanced cancer. Side-effects were minimal.
9. 9 Mannix K. Palliation of nausea and vomiting. In Oxford Textbook of Palliative Medicine, 2nd Edn. Doyle D, Hanks G, MacDonald N (editors). Oxford: Oxford Medical Publications, 1997. pp. 489-499.
10. 10 David D. A survey of the use of syringe drivers in Marie Curie Centres. Eur J Cancer Care 1992; 1:23-28.
11. 11 Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti MT. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliative Medicine 1993; 7:295-299.
12. 12 Riley F, Fallon M. Octreotide in terminal malignant obstruction of the gastrointestinal tract. Eur J Palliative Care 1994; 1:23-25. The use of octreotide is an important development in the pharmacological management of inoperable intestinal obstruction. The drug is expensive but side-effects were few.
13. 13 De Conno F, Caraceni A, Zecca E, Spoldi E, Ventafridda V. The continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Mgmt 1991; 6:484-486.
14. 14 Baines M, Oliver D, Carter R. Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet 1985; ii:990-993.
15. 15 Parker M, Baines M. Intestinal obstruction in patients with advanced malignant disease. Br J Surg 1996; 83:1-2. A brief review of the role of both palliative surgery and pharmacological treatment in intestinal obstruction.
16. 16 Grassby P, Hutchings L. Drug combinations in syringe drivers: the compatibility and stability of diamorphine with cyclizine and haloperidol. Palliative Medicine 1997; 11:217-224.
17. 17 Fallon M. The physiology of somatostatin and its synthetic analogue, octreotide. Eur J Palliative Care 1994; 1:20-22.
18. 18 Mercadante S. Tolerability of continuous subcutaneous octreotide used in combination with other drugs. Eur J Palliative Care 1995; 11:14-16.
19. 19 Fainsinger R, MacEachern T, Miller M, Bruera E, Spachynski K, Kuehn N, Hanson J. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Mgmt 1994; 9:298-302.
20. 20 Sykes N. A volunteer model for the comparison of laxatives in opioid-related constipation. J Pain Symptom Mgmt 1996; 11:363-369.